SCOLR’s Extended-Release Ibuprofen Plans Ramp Up After Break With Wyeth
This article was originally published in The Tan Sheet
Executive Summary
SCOLR Pharma plans to submit a new drug application for its extended-release ibuprofen to FDA in the latter half of 2008